TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,781,140 | -75.1% | 213,055 | -28.3% | 0.00% | -88.9% |
| Q2 2023 | $7,165,468 | +416739.3% | 297,199 | +152.9% | 0.01% | +200.0% |
| Q1 2023 | $1,719 | -99.6% | 117,500 | +77.5% | 0.00% | – |
| Q3 2022 | $396,000 | +32.4% | 66,200 | -4.3% | 0.00% | – |
| Q2 2022 | $299,000 | -67.8% | 69,200 | -26.9% | 0.00% | -100.0% |
| Q1 2022 | $930,000 | -67.4% | 94,620 | -35.8% | 0.00% | -75.0% |
| Q4 2021 | $2,853,000 | -36.1% | 147,428 | +10.8% | 0.00% | -20.0% |
| Q3 2021 | $4,466,000 | -4.1% | 133,034 | +7.4% | 0.01% | -28.6% |
| Q2 2021 | $4,659,000 | -8.1% | 123,859 | +10.6% | 0.01% | 0.0% |
| Q1 2021 | $5,072,000 | -64.5% | 111,999 | -58.5% | 0.01% | -68.2% |
| Q4 2020 | $14,277,000 | +132.0% | 269,929 | +14.8% | 0.02% | +46.7% |
| Q3 2020 | $6,153,000 | +32.4% | 235,102 | -6.0% | 0.02% | +15.4% |
| Q2 2020 | $4,648,000 | +16.3% | 250,215 | -35.4% | 0.01% | +8.3% |
| Q1 2020 | $3,996,000 | -6.4% | 387,218 | -1.6% | 0.01% | +9.1% |
| Q4 2019 | $4,271,000 | +144.1% | 393,576 | +27.1% | 0.01% | +120.0% |
| Q3 2019 | $1,750,000 | -9.5% | 309,757 | +38.5% | 0.01% | -16.7% |
| Q2 2019 | $1,934,000 | -16.5% | 223,593 | -22.4% | 0.01% | -14.3% |
| Q1 2019 | $2,317,000 | +71.5% | 288,201 | -15.1% | 0.01% | +75.0% |
| Q4 2018 | $1,351,000 | -39.8% | 339,430 | -15.3% | 0.00% | -33.3% |
| Q3 2018 | $2,244,000 | -53.1% | 400,535 | +18.8% | 0.01% | -50.0% |
| Q2 2018 | $4,787,000 | 0.0% | 337,126 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $4,787,000 | +115.0% | 337,126 | +79.4% | 0.01% | +50.0% |
| Q3 2017 | $2,226,000 | +23.5% | 187,900 | +10.6% | 0.01% | 0.0% |
| Q2 2017 | $1,802,000 | +8.4% | 169,950 | +17.1% | 0.01% | -11.1% |
| Q1 2017 | $1,662,000 | +1122.1% | 145,100 | +393.7% | 0.01% | – |
| Q4 2016 | $136,000 | +88.9% | 29,390 | +143.8% | 0.00% | – |
| Q2 2016 | $72,000 | – | 12,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |